PSG9 Protein (AA 35-426) (His tag)

Catalog No. ABIN1880612

This Recombinant PSG9 protein is produced in Human Cells.

Quick Overview for PSG9 Protein (AA 35-426) (His tag) (ABIN1880612)

Target: PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))

Protein Type: Recombinant

Origin: Human

Source: Human Cells

Purity: > 95 % as determined by reducing SDS-PAGE.

Product Details

Protein Characteristics: AA 35-426

Purification tag / Conjugate: This PSG9 protein is labelled with His tag.

Purpose: Recombinant Human Pregnancy-Specific β-1-Glycoprotein 9/PSBG9 (C-6His)

Sequence: EVTIEAQPPK VSEGKDVLLL VHNLPQNLPG YFWYKGEMTD LYHYIISYIV DGKIIIYGPA YSGRETVYSN ASLLIQNVTR KDAGTYTLHI IKRGDETREE IRHFTFTLYL ETPKPYISSS NLNPREAMEA VRLICDPETL DASYLWWMNG QSLPVTHRLQ LSKTNRTLYL FGVTKYIAGP YECEIRNPVS ASRSDPVTLN LLPKLPIPYI TINNLNPREN KDVLAFTCEP KSENYTYIWW LNGQSLPVSP GVKRPIENRI LILPSVTRNE TGPYQCEIQD RYGGLRSNPV ILNVLYGPDL PRIYPSFTYY RSGENLDLSC FTESNPPAEY FWTINGKFQQ SGQKLFIPQI TRNHSGLYAC SVHNSATGKE ISKSMTVKVS GPCHGDLTES QSVDHHHHHH

Characteristics: Recombinant Human Pregnancy-specific beta-1-glycoprotein 9/PSG9/PSG11 is produced by our mammalian expression system in human cells. The target protein is expressed with sequence (Glu35-Ser426) of Human PSG9 fused with a polyhistidine tag at the C-terminus.

Sterility: 0.2 μm filtered

Endotoxin Level: Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: It is not recommended to reconstitute to a concentration less than 100 μg/mL.
Dissolve the lyophilized protein in ddH2O.
Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

Buffer: Supplied as a 0.2 μm filtered solution of 20 mM PB,150 mM NaCl, pH 7.5.

Handling Advice: Always centrifuge tubes before opening. Do not mix by vortex or pipetting.

Storage: -80 °C

Storage Comment: Store at < -20°C, stable for 6 months after receipt.
Please minimize freeze-thaw cycles.

Expiry Date: 6 months

Target Details

Target: PSG9 (Pregnancy Specific beta-1-Glycoprotein 9 (PSG9))

Alternative Name: PSG9

Sub Type: Fusionprotein

Background: Pregnancy-specific beta-1-glycoprotein 9(PSG9) is a secreted protein and contains 3 Ig-like C2-type (immunoglobulin-like) domains, 1 Ig-like V-type (immunoglobulin-like) domain. It is a member of the PSG family, a group of closely related secreted glycoproteins that are highly expressed in fetal placental syncytiotrophoblast cells. The members of the PSG protein family all have a characteristic N-terminal domain that is homologous to the immunoglobulin variable region. PSGs become detectable in serum during the first two to three weeks of pregnancy and increase as the pregnancy progresses, eventually representing the most abundant fetal protein in the maternal blood at term. PSGs function to stimulate secretion of TH2-type cytokines from monocytes, and they may also modulate the maternal immune system during pregnancy, thereby protecting the semi-allotypic fetus from rejection. PSGs are commonly expressed in trophoblast tumors. Eleven human PSG proteins (PSG1-PSG11) have been described.
Alternative Names: Pregnancy-specific beta-1-glycoprotein 9, PS-beta-G-9, PSBG-9, Pregnancy-specific glycoprotein 9, PS34, Pregnancy-specific beta-1 glycoprotein B, PS-beta-B, Pregnancy-specific beta-1-glycoprotein 11, PS-beta-G-11, PSBG-11, Pregnancy-specific glycoprotein

Molecular Weight: 45.6 kDa

UniProt: Q00887